🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Many people with type 2 diabetes cannot maintain target blood glucose level...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2005-03
Trial ID
NCT00106340
Treatments Being Tested
This is a study to evaluate the efficacy and safety of ertugliflozin (MK-88...
Status
Completed
Location
Multiple Locations
Start Date
2014-09-23
Trial ID
NCT02226003
Treatments Being Tested
The purpose of this study is to investigate the effect of bexagliflozin com...
Status
Completed
Location
Research Site
Start Date
2016-08-15
Trial ID
NCT02769481
Treatments Being Tested
The purpose of this study is to prevent major cardiovascular events (heart ...
Status
Completed
Location
Minneapolis Medical Research Foundation
Start Date
1999-09
Trial ID
NCT00000620
The purpose of this study is to evaluate the effect of TAK-875 compared to ...
Status
Terminated
Location
Multiple Locations
Start Date
2013-04
Trial ID
NCT01829477
Treatments Being Tested
This is a study to understand efficacy and safety of investigational agent ...
Status
Completed
Location
Sierra Clinical Research
Start Date
2012-02
Trial ID
NCT01517373
Treatments Being Tested
The primary objectives of this study are to determine if sitagliptin treatm...
Status
Completed
Location
Multiple Locations
Start Date
2010-08-16
Trial ID
NCT01189890
Treatments Being Tested
The purpose of this study is to determine the pharmacokinetics and safety o...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01496443
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of albigl...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-02
Trial ID
NCT00839527
The purpose of this study is to assess the efficacy and safety of sitaglipt...
Status
Terminated
Location
Multiple Locations
Start Date
2012-10-10
Trial ID
NCT01678820